Collagen Type VII

"Collagen Type VII" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A non-fibrillar collagen involved in anchoring the epidermal BASEMENT MEMBRANE to underlying tissue. It is a homotrimer comprised of C-terminal and N-terminal globular domains connected by a central triple-helical region.

Descriptor ID

D024143

MeSH Number(s)

D12.776.860.300.250.400.300

Concept/Terms

Collagen Type VII

Procollagen Type VII

Collagen Type VII, alpha1 Subunit

Below are MeSH descriptors whose meaning is more general than "Collagen Type VII".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Scleroproteins [D12.776.860]
Extracellular Matrix Proteins [D12.776.860.300]
Collagen [D12.776.860.300.250]
Non-Fibrillar Collagens [D12.776.860.300.250.400]
Collagen Type VII [D12.776.860.300.250.400.300]

Below are MeSH descriptors whose meaning is related to "Collagen Type VII".

Below are MeSH descriptors whose meaning is more specific than "Collagen Type VII".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Collagen Type VII" by people in Harvard Catalyst Profiles by year, and whether "Collagen Type VII" was a major or minor topic of these publication.

Bar chart showing 13 publications over 10 distinct years, with a maximum of 2 publications in 2009 and 2017 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2007	0	1	1
2008	1	0	1
2009	1	1	2
2010	1	0	1
2012	1	0	1
2013	0	1	1
2015	0	1	1
2017	2	0	2
2020	0	2	2
2021	0	1	1

Below are the most recent publications written about "Collagen Type VII" by people in Profiles.

ABCB5+ dermal mesenchymal stromal cells with favorable skin homing and local immunomodulation for recessive dystrophic epidermolysis bullosa treatment. Stem Cells. 2021 07; 39(7):897-903.

View in: PubMed
Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma. J Invest Dermatol. 2021 04; 141(4):942-946.

View in: PubMed
A novel pathogenic mutation in the COL7A1 gene resulting in mild autosomal dominant bullous dermolysis of the newborn. Pediatr Dermatol. 2020 Sep; 37(5):955-957.

View in: PubMed
An RNA-targeted therapy for dystrophic epidermolysis bullosa. Nucleic Acids Res. 2017 Sep 29; 45(17):10259-10269.

View in: PubMed
Rapid generation of Col7a1-/- mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells. Lab Invest. 2017 10; 97(10):1218-1224.

View in: PubMed
Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa. J Pediatr. 2015 Sep; 167(3):765-9.e1.

View in: PubMed
TALEN-based gene correction for epidermolysis bullosa. Mol Ther. 2013 Jun; 21(6):1151-9.

View in: PubMed
An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindred. Pediatr Dermatol. 2012 Nov-Dec; 29(6):725-31.

View in: PubMed
Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa. Dermatol Clin. 2010 Jan; 28(1):93-105.

View in: PubMed
Fluorescent protein markers to tag collagenous proteins: the paradigm of procollagen VII. Biochem Biophys Res Commun. 2009 Dec 18; 390(3):662-6.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Pediatr Dermatol
Dermatol Online J
Oncology
Nucleic Acids Res
Lab Invest
J Biol Chem
Dermatol Clin
Biochem Biophys Res Commun
J Immunol
Exp Cell Res